24 June 2021

This roundtable discussion will feature three HPC experts sharing their opinions on how changes in the HPC landscape might affect scientists and researchers in the near future

03 June 2021

Join us live on 15 June 2021 @ 2pm (UK) or on demand thereafter.

Register now

11 May 2021

Artificial intelligence (AI) has long been heralded as a game-changer for the pharmaceutical industry, so why are there so few drugs on the market today that resulted from AI?

10 February 2021

In the last five years – since a wide coalition of stakeholders set out and endorsed the application of FAIR principles to research – the principles of findability, accessibility, interoperability, and reusability have become widely recognised and accepted.

10 November 2020

Now available on demand: Join Ansys and Intel to gain insight into how you can optimise your hardware and software deployments for best performance

21 October 2020

Unstructured scientific data is one of the biggest strategic risks to the pharmaceutical industry today

28 September 2020

AI technologies being developed today will lead to new capabilities tomorrow and enable new business applications the day after.